Code of Federal Regulations · Subpart
Subpart B — Designation Of A Minor Use Or Minor Species New Animal Drug
21 C.F.R. pt. 516, subpt. B
- § 516.11 Scope Of This Subpart
- § 516.12 Purpose
- § 516.13 Definitions
- § 516.14 Submission Of Requests For Designation
- § 516.16 Eligibility To Request Designation
- § 516.20 Content And Format Of A Request For Mums-drug Designation
- § 516.21 Documentation Of Minor Use Status
- § 516.22 Permanent-resident U.s. Agent For Foreign Sponsor
- § 516.23 Timing Of Requests For Mums-drug Designation
- § 516.24 Granting Mums-drug Designation
- § 516.25 Refusal To Grant Mums-drug Designation
- § 516.26 Amendment To Mums-drug Designation
- § 516.27 Change In Sponsorship
- § 516.28 Publication Of Mums-drug Designations
- § 516.29 Termination Of Mums-drug Designation
- § 516.30 Annual Reports For A Mums-designated Drug
- § 516.31 Scope Of Mums-drug Exclusive Marketing Rights
- § 516.34 Fda Recognition Of Exclusive Marketing Rights
- § 516.36 Insufficient Quantities Of Mums-designated Drugs
- § 516.52 Availability For Public Disclosure Of Data And Information In Requests